Literature DB >> 19239895

RNA and disease.

Thomas A Cooper1, Lili Wan, Gideon Dreyfuss.   

Abstract

Cellular functions depend on numerous protein-coding and noncoding RNAs and the RNA-binding proteins associated with them, which form ribonucleoprotein complexes (RNPs). Mutations that disrupt either the RNA or protein components of RNPs or the factors required for their assembly can be deleterious. Alternative splicing provides cells with an exquisite capacity to fine-tune their transcriptome and proteome in response to cues. Splicing depends on a complex code, numerous RNA-binding proteins, and an enormously intricate network of interactions among them, increasing the opportunity for exposure to mutations and misregulation that cause disease. The discovery of disease-causing mutations in RNAs is yielding a wealth of new therapeutic targets, and the growing understanding of RNA biology and chemistry is providing new RNA-based tools for developing therapeutics.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19239895      PMCID: PMC2866189          DOI: 10.1016/j.cell.2009.02.011

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  148 in total

1.  Correction of SMN2 Pre-mRNA splicing by antisense U7 small nuclear RNAs.

Authors:  Csilla Madocsai; Sharlene R Lim; Till Geib; Bianca J Lam; Klemens J Hertel
Journal:  Mol Ther       Date:  2005-10-14       Impact factor: 11.454

2.  Multiple and specific mRNA processing targets for the major human hnRNP proteins.

Authors:  Julian P Venables; Chu-Shin Koh; Ulrike Froehlich; Elvy Lapointe; Sonia Couture; Lyna Inkel; Anne Bramard; Eric R Paquet; Valérie Watier; Mathieu Durand; Jean-François Lucier; Julien Gervais-Bird; Karine Tremblay; Panagiotis Prinos; Roscoe Klinck; Sherif Abou Elela; Benoit Chabot
Journal:  Mol Cell Biol       Date:  2008-07-21       Impact factor: 4.272

3.  Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing.

Authors:  Qun Pan; Ofer Shai; Leo J Lee; Brendan J Frey; Benjamin J Blencowe
Journal:  Nat Genet       Date:  2008-11-02       Impact factor: 38.330

4.  Variation in retinitis pigmentosa-11 (PRPF31 or RP11) gene expression between symptomatic and asymptomatic patients with dominant RP11 mutations.

Authors:  Carlo Rivolta; Terri L McGee; Thomas Rio Frio; Roderick V Jensen; Eliot L Berson; Thaddeus P Dryja
Journal:  Hum Mutat       Date:  2006-07       Impact factor: 4.878

5.  A negative element in SMN2 exon 7 inhibits splicing in spinal muscular atrophy.

Authors:  Tsuyoshi Kashima; James L Manley
Journal:  Nat Genet       Date:  2003-08       Impact factor: 38.330

Review 6.  The fragile-X premutation: a maturing perspective.

Authors:  Paul J Hagerman; Randi J Hagerman
Journal:  Am J Hum Genet       Date:  2004-03-29       Impact factor: 11.025

7.  Defining the regulatory network of the tissue-specific splicing factors Fox-1 and Fox-2.

Authors:  Chaolin Zhang; Zuo Zhang; John Castle; Shuying Sun; Jason Johnson; Adrian R Krainer; Michael Q Zhang
Journal:  Genes Dev       Date:  2008-09-15       Impact factor: 11.361

Review 8.  Expression strategies for short hairpin RNA interference triggers.

Authors:  John J Rossi
Journal:  Hum Gene Ther       Date:  2008-04       Impact factor: 5.695

9.  RNA-binding proteins hnRNP A2/B1 and CUGBP1 suppress fragile X CGG premutation repeat-induced neurodegeneration in a Drosophila model of FXTAS.

Authors:  Oyinkan A Sofola; Peng Jin; Yunlong Qin; Ranhui Duan; Huijie Liu; Maria de Haro; David L Nelson; Juan Botas
Journal:  Neuron       Date:  2007-08-16       Impact factor: 17.173

10.  Increased steady-state levels of CUGBP1 in myotonic dystrophy 1 are due to PKC-mediated hyperphosphorylation.

Authors:  N Muge Kuyumcu-Martinez; Guey-Shin Wang; Thomas A Cooper
Journal:  Mol Cell       Date:  2007-10-12       Impact factor: 17.970

View more
  538 in total

Review 1.  RNA Structural Differentiation: Opportunities with Pattern Recognition.

Authors:  Christopher S Eubanks; Amanda E Hargrove
Journal:  Biochemistry       Date:  2018-12-18       Impact factor: 3.162

2.  Muscle weakness in myotonic dystrophy associated with misregulated splicing and altered gating of Ca(V)1.1 calcium channel.

Authors:  Zhen Zhi Tang; Viktor Yarotskyy; Lan Wei; Krzysztof Sobczak; Masayuki Nakamori; Katy Eichinger; Richard T Moxley; Robert T Dirksen; Charles A Thornton
Journal:  Hum Mol Genet       Date:  2011-12-02       Impact factor: 6.150

Review 3.  Neurodegeneration the RNA way.

Authors:  Abigail J Renoux; Peter K Todd
Journal:  Prog Neurobiol       Date:  2011-11-03       Impact factor: 11.685

Review 4.  Cancer and neurodegenerative disorders: pathogenic convergence through microRNA regulation.

Authors:  Liqin Du; Alexander Pertsemlidis
Journal:  J Mol Cell Biol       Date:  2011-01-28       Impact factor: 6.216

5.  Antisense oligonucleotides shed new light on the pathogenesis and treatment of spinal muscular atrophy.

Authors:  Jiing-Kuan Yee; Ren-Jang Lin
Journal:  Mol Ther       Date:  2012-01       Impact factor: 11.454

6.  Concentration-dependent control of pyruvate kinase M mutually exclusive splicing by hnRNP proteins.

Authors:  Mo Chen; Charles J David; James L Manley
Journal:  Nat Struct Mol Biol       Date:  2012-02-05       Impact factor: 15.369

Review 7.  mRNA transcript diversity creates new opportunities for pharmacological intervention.

Authors:  Elizabeth S Barrie; Ryan M Smith; Jonathan C Sanford; Wolfgang Sadee
Journal:  Mol Pharmacol       Date:  2012-02-07       Impact factor: 4.436

8.  An antisense microwalk reveals critical role of an intronic position linked to a unique long-distance interaction in pre-mRNA splicing.

Authors:  Natalia N Singh; Katrin Hollinger; Dhruva Bhattacharya; Ravindra N Singh
Journal:  RNA       Date:  2010-04-22       Impact factor: 4.942

9.  Enantioselective Synthesis of Spliceostatin G and Evaluation of Bioactivity of Spliceostatin G and Its Methyl Ester.

Authors:  Arun K Ghosh; Guddeti Chandrashekar Reddy; Andrew J MacRae; Melissa S Jurica
Journal:  Org Lett       Date:  2017-12-08       Impact factor: 6.005

Review 10.  Targeting RNA in mammalian systems with small molecules.

Authors:  Anita Donlic; Amanda E Hargrove
Journal:  Wiley Interdiscip Rev RNA       Date:  2018-05-03       Impact factor: 9.957

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.